Tuspark Technology Investment Europe
/ 25C, Boulevard Royal
L-2449 Luxembourg
LU
Tuspark Technology Investment Europe
Foundation date
02/11/2017
Sector
#InvestorSubsector
Tuspark Technology Investment Europe S.a r.l. is a Luxembourg-based investment company that focuses on investing in innovative technology companies. Tuspark Technology Investment Europe is a subsidiary of Tus-Holdings Co., Ltd.. Tuspark Technology Investment Europe is particularly interested in investing in companies that are involved in biotechnology, and clean technology. Its business focus is on (1) investment: identifying innovative companies that have the potential to disrupt traditional industries and create new markets, providing early-stage funding, with the aim of helping startups to grow and scale their businesses; (2) incubation: the firm also provides strategic guidance and support to its portfolio companies, helping them to navigate the challenges of scaling a business and reach their full potential. Through its network of industry experts and advisors, Tuspark Technology Investment Europe S.a r.l. aims to connect its portfolio companies with the resources and expertise they need to succeed.
Upcoming events
All events-
1605 '24
Knowledge for Growth 2024
Event by: flanders.bio -
1505 '24
State of the Union by VIB & flanders.bio
Event by: flanders.bio & VIB -
2105 '24
IOT Solutions World Congress 2024
Event by: Fira Barcelona
Latest news
More news-
V-Bio Ventures leads €20 million Series A financing of Precision oncology company Flindr Therapeutics to advance first-in-class small molecule inhibitors
1 day ago
Read more
-
Labconsort and NEKTARI join forces for a more sustainable and social industry
Saturday April 20th 2024
Read more
-
BIO INX Complements Advisory Board with Distinguished Industry Leaders
Thursday April 18th 2024
Read more
Jobs
More jobs-
-
24/04/24
Brussels
Laboratory Technician / Scientific Collaborator in Protein Biochemistry
Permanent
VIB -
23/04/24
Brussels
PhD Student Position: Fluorescent Biosensors in Neurodegenerative Diseases
Permanent
VIB
More info?
Ellen Telleir
Communication Coordinator